DANIEL L KISNER Insider Trading $ONCT Oncternal Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL L KISNER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL L KISNER. DANIEL L KISNER is Director in SEQUENOM INC ($SQNM) and Director in DYNAVAX TECHNOLOGIES CORP ($DVAX) and Director in Oncternal Therapeutics, Inc. ($GTXI) and Director in LPATH, INC ($LPTN) and Director in Conatus Pharmaceuticals Inc. ($CNAT) and Director in Zynerba Pharmaceuticals, Inc. ($ZYNE).

DANIEL L KISNER in Oncternal Therapeutics, Inc.

Trading Symbol: ONCT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL L KISNER: Director
Holdings: 10,000 shares
Current Value: $55,800
Latest Transaction: Jul 23 2020
$ONCT Market Capitalization: $86.92M
$ONCT Previous Close: $5.58

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DANIEL L KISNER in Oncternal Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, LPTN, DVAX, HSTO, ONCT, SQNM, ZYNE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 23 2020ONCTOncternal Therapeu ...KISNER DANIEL LDirectorOption ExerciseA2.325,00011,6005,000
Jul 23 2020ONCTOncternal Therapeu ...KISNER DANIEL LDirectorBuyP2.3810,00023,82510,0000 to 10 K
Jun 12 2020ONCTOncternal Therapeu ...KISNER DANIEL LDirectorOption ExerciseA2.9415,00044,10015,000
Sep 16 2019GTXIOncternal Therapeu ...KISNER DANIEL LDirectorOption ExerciseA5.7630,000172,80030,000

Page:   1